121 related articles for article (PubMed ID: 15704674)
1. [Design, development and successful application of safe and effective HIV therapeutic and prophylactic vaccines].
Abalaka JO
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):8-16. PubMed ID: 15704674
[TBL] [Abstract][Full Text] [Related]
2. Attempts to cure and prevent HIV/AIDS in central Nigeria between 1997 and 2002: opening a way to a vaccine-based solution to the problem?
Abalaka JO
Vaccine; 2004 Sep; 22(29-30):3819-28. PubMed ID: 15364427
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic vaccination against HIV: current progress and future possibilities.
Puls RL; Emery S
Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
[TBL] [Abstract][Full Text] [Related]
4. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
5. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
White A
Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
8. HIV vaccines: brief review and discussion of future directions.
Slobod KS; Bonsignori M; Brown SA; Zhan X; Stambas J; Hurwitz JL
Expert Rev Vaccines; 2005 Jun; 4(3):305-13. PubMed ID: 16026246
[TBL] [Abstract][Full Text] [Related]
9. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
10. [Vaccines against HIV].
Holm-Hansen C
Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
[TBL] [Abstract][Full Text] [Related]
11. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
Leligdowicz A; Rowland-Jones S
Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
14. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS.
Lesi OA; Kehinde MO; Oguh DN; Amira CO
Niger Postgrad Med J; 2007 Jun; 14(2):129-33. PubMed ID: 17599111
[TBL] [Abstract][Full Text] [Related]
16. A potent weapon in the battle against HIV: your own immune system.
Proj Inf Perspect; 2002 Mar; (34):14-6. PubMed ID: 12038300
[TBL] [Abstract][Full Text] [Related]
17. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 vaccine clinical trials: the Brazilian experience.
Ersching J; Pinto AR
Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
[TBL] [Abstract][Full Text] [Related]
19. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic vaccines against HIV need international partnerships.
Autran B; Debré P; Walker B; Katlama C
Nat Rev Immunol; 2003 Jun; 3(6):503-8. PubMed ID: 12776210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]